Schmidt JB, Gregersen NT, Pedersen SD, Arentoft JL, Ritz C, Schwartz TW et al
Boston University and UMass Memorial Health said they will stop covering GLP-1s for weight loss next year, with the latter saying it spent $20 million on the drugs just in the past year
There are reports of suicidality with use of these drugs, but a large observational study showed a statistically significantly lower rate of suicidal ideation compared to a matched group
Semaglutide has been shown in animal studies to reduce ovarian inflammation in mice with PMOS, and early human research hints at similar anti-inflammatory effects
Please see Medication Guide and Prescribing Information, including Boxed Warning, for Wegovy at About Novo Nordisk Novo Nordisk is a leading global healthcare company that's been making innovative medicines to help people with diabetes lead longer, healthier lives for more than 100 years
Who may benefit